Colchicine and Inflammation in Aortic Stenosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

Also called NCT05162742

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05162742
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05162742. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-22 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine and Inflammation in Aortic Stenosis
Acronym
CHIANTI
Condition
Aortic Valve Disease
Condition
Aortic Valve Stenosis
Condition
Aortic Valve Calcification
Condition
Inflammation
Condition
Calcification
Condition
Cardiovascular Diseases
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Radboud University Medical Center (class: other)

Record details

Record id
cardio:ct-nct05162742
Content hash
d6ffb1db47837edd587336648f5972ea49187a549338a3ff0d0f9bf53c815e82